On Tuesday, shares of embattled cruise company Norwegian Cruise Line NCLH plummeted. The stock was down about 19% in late morning trading after it warned that it may have to seek bankruptcy protection.
NCL was down 22.5% at the closing bell.
Norwegian said in an SEC filing that there’s “substantial doubt” about its ability to continue as a business. The company had roughly $6 billion in long-term debt as of Dec. 31, and if Norwegian can’t amend its credit agreements, it said it would be at risk for default.
Because of the Covid-19 pandemic, Norwegian had to suspend its entire fleet beginning March 14, and the shutdown has now been extended through at least June 30. The company also furloughed 20% of its shoreside staff.
The pandemic has hit the cruise industry particularly hard, with Royal Carribbean RCL and Carnival CCL forced to shut down operations as well.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Carnival Corporation (CCL) : Free Stock Analysis Report
Royal Caribbean Cruises Ltd. (RCL) : Free Stock Analysis Report
Norwegian Cruise Line Holdings Ltd. (NCLH) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research